Page last updated: 2024-08-24

irinotecan and Cystadenocarcinoma, Papillary

irinotecan has been researched along with Cystadenocarcinoma, Papillary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Inoue, S; Kagawa, M; Kusanishi, H; Watanabe, Y	1

Other Studies

1 other study(ies) available for irinotecan and Cystadenocarcinoma, Papillary

Article	Year
[A case of ovarian cancer in which a remarkable effect was seen with low-dose CDDP intratumoral injection of CPT-11]. Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:12 Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Cisplatin; Cystadenocarcinoma, Papillary; Drug Therapy, Combination; Female; Humans; Injections, Intralesional; Injections, Intravenous; Irinotecan; Middle Aged; Ovarian Neoplasms; Peritonitis	2002

Article

Year

[A case of ovarian cancer in which a remarkable effect was seen with low-dose CDDP intratumoral injection of CPT-11].

Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:12

Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Cisplatin; Cystadenocarcinoma, Papillary; Drug Therapy, Combination; Female; Humans; Injections, Intralesional; Injections, Intravenous; Irinotecan; Middle Aged; Ovarian Neoplasms; Peritonitis

2002